In 2024, HTA Accelerator and Prismaccess will become IQVIA Market Access Insights. This new platform combines the key of both previous tools to create one best-in-class solution. Market Access Insights will provide access to comprehensive, relevant, and actionable content so that you can make informed market access decisions.
Download the factsheet to learn more or click on the "Request Demo" button to request a personal introduction to the new platform.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Access clearer, more compelling support to demonstrate the value of your product.
Get insights into payer decision making and evidence requirements to accelerate market access for your drug.
